Hodge W G

Hodge W G, Lachaine J, Steffensen I, Murray C, Barnes D, Foerster V et al.

This review found latanoprost lowers IOP more than dorzolamide, but similarly to brimonidine, which caused more ocular side effects. This guides glaucoma treatment choices.

Damji K F, Bovell A M, Hodge W G, Rock W, Shah K, Buhrmann R et al.

This study compared SLT and ALT for open-angle glaucoma, finding both equally effective at lowering IOP at one year with similar safety, making both viable treatment options.

Damji K F, Konstas A G P, Liebmann J M, Hodge W G, Ziakas N G, Giannikakis S et al.

Cataract surgery lowers eye pressure more significantly in patients with exfoliation syndrome, especially those with glaucoma, an effect lasting at least two years.

Hodge W G, Damji K F, Rock W, Buhrmann R, Bovell A M, Pan Y

This study found baseline intraocular pressure strongly predicts SLT success in glaucoma patients, meaning higher initial pressure correlates with better treatment outcomes, guiding patient selection.

Munger R, Dohadwala A A, Hodge W G, Jackson W B, Mintsioulis G, Damji K F

Hyperopic PRK lowers measured IOP, similar to myopic PRK, despite minimal corneal thinning, indicating biomechanical changes. Clinically, this means post-PRK IOP readings may be falsely low, impacting glaucoma diagnosis and management.

Allingham R R, Loftsdottir M, Gottfredsdottir M S, Thorgeirsson E, Jonasson F, Sverisson T et al.

This study found pseudoexfoliation syndrome (PXF) is a familial, maternally inherited condition in Icelandic families, strongly associated with glaucoma but not age-related macular degeneration or systemic diseases.

Merkur A, Damji K F, Mintsioulis G, Hodge W G

Cataract surgery in pseudoexfoliation patients significantly lowered intraocular pressure more than in glaucoma or cataract-only controls, suggesting it can help manage elevated IOP in these patients.

Damji K F, Shah K C, Rock W J, Bains H S, Hodge W G

This study found SLT and ALT similarly lower IOP for 6 months in glaucoma, but SLT was more effective after failed ALT, offering a retreatment option despite slightly more initial inflammation.

Jackson W B, Casson E, Hodge W G, Mintsioulis G, Agapitos P J

Hyperopic PRK for low hyperopia was safe and effective, with 80% of eyes achieving ±0.5 D of target at one year. This shows good predictability and minimal complications for treating low hyperopia.